Our Pricing

Your Highest Dose Of Mounjaro Questions Answered

Understanding the highest dose of Mounjaro UK prescribers can offer is essential for patients considering this advanced weight loss treatment. At Cured Pharmacy, our UK-registered clinical team provides comprehensive guidance on Mounjaro's dose escalation schedule, helping you achieve optimal results safely. Mounjaro (tirzepatide) is available from £135.00 subject to clinical assessment by a UK prescriber.

What Is the Highest Dose of Mounjaro Available in the UK?

The highest dose of Mounjaro licensed by the MHRA for weight management in the UK is 15mg, administered once weekly via subcutaneous injection [1]. This maximum maintenance dose represents the endpoint of a carefully structured escalation schedule designed to optimise efficacy whilst minimising gastrointestinal side effects.

Clinical trials demonstrated that the 15mg dose produced the most significant weight reduction outcomes, with participants in the SURMOUNT-1 trial achieving an average body weight reduction of 20.9% over 72 weeks [1]. However, not all patients require or tolerate the maximum dose — your UK prescriber will determine the appropriate maintenance dose based on your individual response and tolerability.

Mounjaro pens are available in five dose strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. Each KwikPen contains four weekly doses at the specified strength, ensuring consistent dosing throughout your treatment journey [2].

Mounjaro Dose Escalation Schedule Explained

The standard dose escalation protocol for Mounjaro begins at 2.5mg once weekly for the first four weeks. This starting dose is not intended to produce significant weight loss but rather to allow your body to adapt to the medication's mechanism of action [2].

After the initial four-week period, your dose typically increases to 5mg weekly. Subsequent increases occur every four weeks, progressing through 7.5mg, 10mg, and 12.5mg before reaching the maximum 15mg dose if clinically appropriate. This gradual escalation significantly reduces the incidence of nausea, vomiting, and diarrhoea compared to starting at higher doses [1][3].

Some patients achieve their weight loss goals at intermediate doses such as 10mg or 12.5mg and may not require escalation to 15mg. Your UK prescriber will monitor your progress at each stage and adjust the escalation schedule based on your weight loss response, side effect profile, and overall health markers.

Can You Stay on a Lower Dose?

Absolutely. Clinical practice recognises that the optimal Mounjaro dose varies between individuals. If you're experiencing satisfactory weight loss and minimal side effects at 7.5mg or 10mg, your prescriber may recommend maintaining that dose rather than escalating further. The goal is to find the lowest effective dose that delivers meaningful results whilst preserving quality of life [2].

Clinical Results at the Highest Mounjaro Dose

The SURMOUNT-1 trial, which evaluated tirzepatide for chronic weight management, demonstrated remarkable efficacy at the 15mg dose. Participants achieved an average weight reduction of 20.9% from baseline over 72 weeks, compared to 3.1% in the placebo group [1].

More than half (57%) of patients receiving 15mg Mounjaro achieved at least 20% body weight reduction, and 40% achieved 25% or greater reduction — outcomes previously only observed with bariatric surgery [1]. These results represent a significant advancement in pharmacological weight management options available in the UK.

Beyond weight loss, the highest Mounjaro dose produced substantial improvements in cardiometabolic risk factors. Participants experienced reductions in waist circumference averaging 18.5cm, improvements in systolic blood pressure of approximately 7.4mmHg, and favourable changes in lipid profiles [3]. However, individual results vary, and these outcomes occurred within the context of a reduced-calorie diet and increased physical activity.

Comparing Maximum Doses Across Weight Loss Treatments

When compared to semaglutide-based treatments like Wegovy (maximum dose 2.4mg weekly), tirzepatide at 15mg demonstrated superior weight loss outcomes in head-to-head comparisons. The SURPASS-2 trial showed tirzepatide 15mg produced greater weight reduction than semaglutide 1mg, though direct comparison with Wegovy's 2.4mg dose requires further research [4]. Your UK prescriber can discuss which treatment and dose level best suits your medical history and weight loss objectives.

Side Effects at Higher Mounjaro Doses

Gastrointestinal side effects occur more frequently at higher Mounjaro doses, though the gradual escalation protocol significantly mitigates their severity. In clinical trials, nausea was reported by approximately 29% of participants on 15mg, compared to 9% on placebo [1]. Most gastrointestinal symptoms were mild to moderate and diminished over time as patients adapted to the medication.

Other common side effects at the 15mg dose include diarrhoea (affecting approximately 23% of participants), constipation (17%), and vomiting (12%) [1]. These effects typically peak during dose escalation periods and improve with continued use. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these symptoms.

Serious side effects are rare but require immediate medical attention. These include signs of pancreatitis (severe abdominal pain radiating to the back), gallbladder problems, severe allergic reactions, or symptoms of thyroid tumours. Your UK prescriber will review your medical history during consultation to identify any contraindications, and you should report any concerning symptoms promptly to your healthcare provider [2][3].

Who Should Not Take the Highest Mounjaro Dose?

Certain medical conditions preclude the use of Mounjaro at any dose. The medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [2]. Patients with a history of severe gastrointestinal disease, including gastroparesis, may not tolerate higher doses.

Those with a history of pancreatitis should discuss risks carefully with their prescriber, as GLP-1 receptor agonists have been associated with acute pancreatitis in rare cases. Similarly, patients with diabetic retinopathy require careful monitoring when initiating treatment, particularly if rapid glucose changes occur [3].

Pregnancy and breastfeeding are absolute contraindications to Mounjaro use. Women of childbearing potential should use effective contraception during treatment and discontinue Mounjaro at least two months before a planned pregnancy. Your UK prescriber will conduct a thorough medical assessment to ensure Mounjaro is safe and appropriate for your individual circumstances [2].

Age and BMI Requirements

Mounjaro is licensed for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea. The medication has not been studied in patients under 18 or over 75 years of age, and use in these populations requires careful clinical judgement [2].

How to Access Mounjaro at Cured Pharmacy

Accessing Mounjaro through Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. Our UK-registered prescribers review your medical history, current medications, and weight loss goals to determine whether Mounjaro is clinically appropriate and which starting dose is suitable for your circumstances.

If approved, your prescription is issued electronically and dispensed by our GPhC-registered pharmacy (registration number 9012511). Mounjaro pens are shipped in discreet, temperature-controlled packaging to ensure medication integrity. Pricing is transparent from the outset — competitive UK pricing with no hidden consultation fees or surprise charges at checkout.

Ongoing support is central to successful weight loss treatment. Our clinical team remains available throughout your treatment journey to address questions about dose escalation, side effect management, and optimising your results. Follow-up consultations ensure your treatment remains safe and effective as you progress towards your weight loss goals.

All prescription medications at Cured Pharmacy are genuine, UK-licensed products sourced through regulated supply chains. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees dispensing to ensure every patient receives authentic medication and appropriate pharmaceutical care. You can contact our team on (+44) 116 4646009 with any questions about your treatment.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Electronic Medicines Compendium. (2023). Mounjaro 15 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14881
3. Garvey, W. T., Frias, J. P., Jastreboff, A. M., le Roux, C. W., Sattar, N., Aizenberg, D., ... & SURMOUNT-1 Investigators. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X
4. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to a reduced-calorie diet and increased physical activity alongside medication use.